Brian Booth

6.5k total citations · 2 hit papers
77 papers, 4.6k citations indexed

About

Brian Booth is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Brian Booth has authored 77 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 19 papers in Molecular Biology and 17 papers in Oncology. Recurrent topics in Brian Booth's work include Biosimilars and Bioanalytical Methods (21 papers), Statistical Methods in Clinical Trials (10 papers) and Clinical Laboratory Practices and Quality Control (10 papers). Brian Booth is often cited by papers focused on Biosimilars and Bioanalytical Methods (21 papers), Statistical Methods in Clinical Trials (10 papers) and Clinical Laboratory Practices and Quality Control (10 papers). Brian Booth collaborates with scholars based in United States, Canada and Germany. Brian Booth's co-authors include Richard Pazdur, Robert Justice, Rajeshwari Sridhara, Jogarao Gobburu, Russell Weiner, C.T. Viswanathan, Surendra K. Bansal, Vinod P. Shah, Anthony J. DeStefano and Patrick G. Swann and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and The American Journal of Cardiology.

In The Last Decade

Brian Booth

74 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Quantitative Bioanalytical Methods Validation and Implementation: Best Practices for Chromatographic and Ligand Binding Assays

2007 667 citations Brian Booth, Russell Weiner et al. profile →
Approval Summary: Sunitinib for the Treatment of Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors and Advanced Renal Cell Carcinoma

2007 407 citations Jogarao Gobburu, Brian Booth et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian Booth United States	30	1.6k	1.3k	815	699	518	77	4.6k
Hans C. Lee United States	37	1.8k 1.2×	1.7k 1.3×	537 0.7×	679 1.0×	822 1.6×	228	5.3k
Raymond J. Hohl United States	40	2.3k 1.4×	1.5k 1.2×	446 0.5×	624 0.9×	616 1.2×	138	4.9k
Lionel D. Lewis United States	36	1.4k 0.9×	1.7k 1.3×	595 0.7×	806 1.2×	307 0.6×	167	4.2k
Cody J. Peer United States	33	1.8k 1.1×	1.5k 1.2×	626 0.8×	559 0.8×	172 0.3×	156	4.0k
Jogarao Gobburu United States	36	946 0.6×	1.2k 0.9×	317 0.4×	908 1.3×	802 1.5×	163	5.0k
Jian‐Jun Li China	40	834 0.5×	458 0.3×	569 0.7×	620 0.9×	702 1.4×	229	5.5k
K. OGASAWARA Japan	39	950 0.6×	1.5k 1.2×	1.6k 2.0×	268 0.4×	398 0.8×	195	4.9k
Timothy W. Synold United States	39	2.4k 1.5×	2.3k 1.7×	286 0.4×	651 0.9×	521 1.0×	194	5.9k
Akinobu Hamada Japan	36	1.2k 0.7×	1.6k 1.2×	417 0.5×	663 0.9×	351 0.7×	178	3.7k
Teresa Padró Spain	43	2.9k 1.8×	907 0.7×	1.1k 1.4×	439 0.6×	1.6k 3.0×	197	7.2k

Countries citing papers authored by Brian Booth

Since Specialization

Citations

This map shows the geographic impact of Brian Booth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Booth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Booth more than expected).

Fields of papers citing papers by Brian Booth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Booth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Booth. The network helps show where Brian Booth may publish in the future.

Co-authorship network of co-authors of Brian Booth

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Booth. A scholar is included among the top collaborators of Brian Booth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Booth. Brian Booth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Norsworthy, Kelly J., Donna R. Rivera, Joseph Wynne, et al.. (2025). FDA Approval Summary: Abatacept for the Prophylaxis of Acute GVHD. Clinical Cancer Research. 31(15). 3118–3123.

2.

Woods, Ashley, Kelly J. Norsworthy, Moran Choe, et al.. (2024). FDA Approval Summary: Olutasidenib for Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase 1 Mutation. Clinical Cancer Research. 31(1). 12–17. 1 indexed citations

3.

Shord, Stacy S., et al.. (2023). US Food and Drug Administration embraces using innovation to identify optimized dosages for patients with cancer. CPT Pharmacometrics & Systems Pharmacology. 12(11). 1573–1576. 6 indexed citations

4.

Booth, Brian, et al.. (2023). Use of patient-reported outcomes (PRO) data to complement exposure–response analysis in early clinical cancer drug development. Journal of Patient-Reported Outcomes. 7(1). 116–116. 3 indexed citations

5.

Wickremsinhe, Enaksha, Qin Ji, Carol Gleason, Melanie Anderson, & Brian Booth. (2020). Land O’Lakes Workshop on Microsampling: Enabling Broader Adoption. The AAPS Journal. 22(6). 135–135. 14 indexed citations

6.

Arnold, Mark E., Brian Booth, Lindsay King, & Chad Ray. (2016). Workshop Report: Crystal City VI—Bioanalytical Method Validation for Biomarkers. The AAPS Journal. 18(6). 1366–1372. 43 indexed citations

7.

Booth, Brian, Mark E. Arnold, Binodh DeSilva, et al.. (2014). Workshop Report: Crystal City V—Quantitative Bioanalytical Method Validation and Implementation: The 2013 Revised FDA Guidance. The AAPS Journal. 17(2). 277–288. 86 indexed citations

8.

Gao, Hongying, Abigail Jacobs, Ronald E. White, Brian Booth, & R. Scott Obach. (2013). Meeting Report: Metabolites in Safety Testing (MIST) Symposium—Safety Assessment of Human Metabolites: What’s REALLY Necessary to Ascertain Exposure Coverage in Safety Tests?. The AAPS Journal. 15(4). 970–973. 24 indexed citations

9.

Brave, Michael H., Ann T. Farrell, Sarah Pope Miksinski, et al.. (2010). FDA Review Summary: Mozobil in Combination with Granulocyte Colony-Stimulating Factor to Mobilize Hematopoietic Stem Cells to the Peripheral Blood for Collection and Subsequent Autologous Transplantation. Oncology. 78(3-4). 282–288. 100 indexed citations

10.

Ibrahim, Amna, Nancy S. Scher, Grant Williams, et al.. (2003). Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases.. PubMed. 9(7). 2394–9. 157 indexed citations

11.

Booth, Brian & Jogarao Gobburu. (2003). Considerations in Analyzing Single‐Trough Concentrations Using Mixed‐Effects Modeling. The Journal of Clinical Pharmacology. 43(12). 1307–1315. 17 indexed citations

12.

Maurer, Tristan S., et al.. (2000). Examination of N-hydroxylation as a prerequisite mechanism of nitric oxide synthase inactivation. Bioorganic & Medicinal Chemistry Letters. 10(10). 1077–1080. 6 indexed citations

13.

Booth, Brian & Ho‐Leung Fung. (1998). Regulation of in vivo whole blood aggregation in rats by calcitonin gene related peptide. Canadian Journal of Physiology and Pharmacology. 76(7-8). 811–813. 5 indexed citations

14.

Booth, Brian & Ho‐Leung Fung. (1998). Regulation of in vivo whole blood aggregation in rats by calcitonin gene related peptide. Canadian Journal of Physiology and Pharmacology. 76(7-8). 811–813. 6 indexed citations

15.

Booth, Brian, et al.. (1997). Nitroglycerin‐inhibited whole blood aggregation is partially mediated by calcitonin gene‐related peptide–a neurogenic mechanism. British Journal of Pharmacology. 122(3). 577–583. 23 indexed citations

16.

Booth, Brian, Saji Jacob, John Anthony Bauer, & Ho‐Leung Fung. (1996). Sustained Antiplatelet Properties of Nitroglycerin During Hemodynamic Tolerance in Rats. Journal of Cardiovascular Pharmacology. 28(3). 432–438. 18 indexed citations

17.

Bauer, John Anthony, Brian Booth, & Ho‐Leung Fung. (1995). Nitric Oxide Donors: Biochemical Pharmacology and Therapeutics. Advances in pharmacology. 34. 361–381. 44 indexed citations

18.

Booth, Brian, et al.. (1993). Caring for older people : a nurse's guide. Macmillan eBooks.

19.

Booth, Brian, James F. Brien, Gerald S. Marks, & Kanji Nakatsu. (1993). Effect of temperature on glyceryl trinitrate induced relaxation of rabbit aorta. Canadian Journal of Physiology and Pharmacology. 71(8). 629–632. 11 indexed citations

20.

Booth, Brian. (1989). Planning for Quality: Advice respectfully tendered to the Polytechnics and Colleges Funding Council. Higher Education Quarterly. 43(4). 278–288. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact